Immunohistochemical staining was then performed on liver cancer tissue microarrays to investigate the correlation between TCF12 and CD31, as well as to evaluate the impact of TCF12 expression on the prognosis of liver cancer patients. This evidence concerns the gene TCF12 and liver cancer.